Sign in
TerminatedNo phase

Improving Knowledge in Heart Failure Inpatient With Therapeutic Education

Key facts

Who runs it
University Hospital, Geneva
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
38 people enrolled
Started
13 Dec 2022
Ended
31 Jan 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Patient therapeutic education
Record updated
26 March 2024
Why it stopped
Difficulty in recruiting and lack of resources

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Hospitalization in the Department of General Internal Medicine or Cardiology for decompensated heart failure with lowered left ventricular ejection fraction (LVEF) (≤40%) from any cause or mildly lowered LVEF (41-49%) with the presence of heart failure-specific drug therapy
  • Stability of the patient's clinical condition
  • ≥ 2 heart failure medications
  • ≥18 years
  • Full capacity of discernment
  • Absence of cognitive impairment
  • Ability to speak, understand and read in French
  • Get a personal telephone
  • Consent form signed by the participant

Who cannot take part

  • Inability to follow study procedures
  • Institutionalized persons
  • Asylum seekers, homeless people, prisoners
  • Incapacity of judgment and discernment

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective is to evaluate the impact of a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients. The knowledge score on heart failure disease and medications will be compared between two groups one month after hospitalization. The intervention group will receive a therapeutic education intervention and usual hospital care and the control group will receive only usual hospital care.

The 2 groups in the trial

  • "Patient therapeutic education" groupTreatment being tested

    The intervention group will benefit from a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients and usual hospital care (medical and nursing care)

    Treatment: Patient therapeutic education

  • "Usual hospital care" groupNo study treatment, for comparison

    The control group do only benefit from the usual hospital care (any medical and nursing care giving to an acute heart failure inpatient) and won't benefit from the pharmacist's educational intervention.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Disease and Medication Knowledge Improvement: A Swiss Single-center Randomized Controlled Trial With Heart Failure Inpatients
Record updated
26 March 2024